Rasagiline - A novel MAO B inhibitor in Parkinson's disease therapy

Shimon Lecht, Simon Haroutiunian, Amnon Hoffman, Philip Lazarovici

Research output: Contribution to journal › Review article › peer-review

63 Scopus citations

Fingerprint

Dive into the research topics of 'Rasagiline - A novel MAO B inhibitor in Parkinson's disease therapy'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Neuroscience